Back to search

Nemaura Pharma Limited

05636878

liquidation
Private Limited Company
Companies House
Health Score
N/A

Details

1ST FLOOR, FAIRCLOUGH HOUSE, CHORLEY, PR7 4EX
Incorporated 25/11/2005

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Mister Dewan Fazlul Hoque Chowdhury

director · Since 25/11/2005

DIRECTOR

BRITISH · ENGLAND · Age 53

Also on 13 other boards

Persons with Significant Control

Mister Dewan Fazlul Hoque Chowdhury

50–75% shares

British · England · Age 53

1st Floor, Fairclough House, Church Street, Chorley, PR7 4EX

Notified 06/04/2016

Former PSCs

Mr Bashir Timol

Ceased 04/07/2024

Charges0 outstanding

charge
satisfied

TRIAL CLINIC LIMITED

Created 27/09/2011Registered 13/10/2011Satisfied 02/05/2024

CompanyRankvs 15+ SIC 72190 peers
42

Financial strengthNo net worth data · 0/25
EmployeesNo employee data · 0/15
LiquidityCurrent ratio 1.17× · 12/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2023

Net Worth

-£3.2M

Balance sheet strength

Cash

£110k

Cash in the bank

Net Current Assets

£293k

Working capital

Current Assets

£2.0M

Current Liabilities

£1.7M

Fixed Assets

£895k

Debtors

£1.9M

14avg. employees-9

Balance Sheet

Intangible assets£130k
Assets less current liabilities£1.2M
Prepared with Digita Accounts Production Advanced

EstimatesDerived

YearCurrent RatioImplied Profit
20231.17+£78k
20221.11-£319k
20211.19-£927k
20202.74

Derived from filed accounts. Not audited figures.